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Abstract
Background: Sodium butyrate (SB) is reported to regulate lipid metabolism in mammals, and the relationship
between maternal nutrition and offspring growth has drawn much attention in the last several years.
Methods: To elucidate the effects of maternal dietary SB supplementation on hepatic lipid metabolism in weaning
rats, we fed 16 primiparous purebred female SD rats either a chow-diet or a 1 % sodium butyrate diet throughout
pregnancy and lactation. At weaning age, samples of the maternal subcutaneous adipose tissue and offspring liver
were taken. The serum indexes and expressions of proteins related to lipid metabolism were detected in the
mother and offspring, respectively.
Results: The results showed that the maternal SB supplement increased the concentration of non-esterified fatty
acid (NEFA) in the maternal and offspring serum (P < 0.05). Total cholesterol (Tch) increased significantly in the
weaning-rat serum (P < 0.05). Maternal adipose tissue from the SB-supplemented rats showed higher content of
protein G-coupled protein (GPR43) and protein kinase A (PKA) (P < 0.05). The expression of protein adipose
triglyceride lipase (ATGL), and of total and phosphorylated hormone sensitive lipase (HSL), in the maternal adipose
tissue increased significantly (P < 0.05) compared to the control group. However the proteins related to lipogenesis
showed no significant changes. Moreover, the concentration of triglyceride in the offspring liver increased
significantly, and this likely resulted from an increase in the levels of fatty acids binding protein (FABP) and fatty
acid translocase (CD36) protein (P < 0.05). SB exposure during pregnancy and lactation increased the hepatic total
cholesterol (Tch) content (P < 0.01), which was related to a significantly up-regulated offspring hepatic expression
of low density lipoprotein receptor (LDLR) protein (P < 0.05).
Conclusion: These results indicate that a maternal SB supplement during pregnancy and the lactation period
promotes maternal fat mobilization, which may result in fatty acid uptake and lipid accumulation in the liver
of the offspring.
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Background
Lines of evidence indicate that maternal nutrition during
pregnancy and lactation is closely related to the adequate
development of offspring [1]. The offspring’s metabolism
is dependent on substrates from maternal nutrients, and
one of the most important nutritional substances is fatty
acid (FA) [2]. FAs are responsible for the growth of cell
membranes, as well as for maintaining their appropriate
fluidity and permeability, [3] and they are involved in en-
ergetic and metabolic processes [4]. The maternal FA level
is positively related to the offspring’s fat percentage, and
transporting FAs from mother to offspring is positively
correlated with offspring development, particularly during
the late gestation period, when deposition of fat in the
fetus increases sharply [5]. It has been shown that mater-
nal triglycerides (TG) and free fatty acid levels have a close
relationship with both weight and fat mass of infants [3].
FA deficiency and disruption in the maternal-placental
offspring metabolism lead to malnutrition of the fetus,
and metabolic diseases may appear in the later life of the
offspring [6, 7].
Short chain fatty acids (SCFA) can be found in foods
and are the main products of the intestinal fermentation
of soluble fiber, which contains abundant quantities of
acetate, propionate and butyrate [8, 9]. Butyrate acts as
the major intestinal fuel, supplying 60–70 % of the energy
needs of the colonocytes [10, 11]. Increasing evidence have
shown that butyrate affects body lipid metabolism [12–14].
Several studies have discussed the treatment of butyrate re-
duced intracellular lipolytic activity or enhanced adipogen-
esis [11, 15]. Other reports have suggested that incubation
of 3 T3-L1 adipocytes with high concentrations of butyrate
resulted in an increased lipolytic response [16]. In a high-
fat animal model, treatment with sodium butyrate (SB) can
lead to loss of body weight or reverse gains in body weight
and adiposity [17, 18].
Regarding supplemental SB in the maternal diet, lines
of evidence have indicated that SB can promote the
growth performance of weaning pigs [19–21]. However,
the effect of a maternal SB supplement on the maternal
lipid metabolism is unknown. Furthermore, if SB influ-
ences the mother’s lipid metabolism, it remains largely un-
clear whether this effect will exert its action on offspring
lipid accumulation.
The liver performs a key role in lipid metabolism,
importing free fatty acids, manufacturing and exporting
lipids to provide energy, and storing excess lipids, thus
making the liver responsible for lipid homeostasis [22]. It
has been shown that maternal pre-pregnancy body weight
is associated with offspring hepatic fat storage [23].
Maternal obesity may result in offspring overgrowth and
increased lipid deposition in fetuses [24]; moreover, an
excess of lipid deposition can lead to postnatal hepatic
dysfunction and even non-alcoholic steatohepatitis [25].
The influence of maternal SB on offspring hepatic lipid
metabolism needs to be investigated.
We conducted this study to determine the effects of
maternal butyrate supplementation on the potential rela-
tionship between maternal lipid metabolism in white
adipose tissue and offspring hepatic lipid accumulation
during pregnancy and the lactation period. This is the
first study to examine whether a relationship exists be-
tween maternal serum NEFA and offspring hepatic lipid
accumulation. Overall, our results will provide scientific
research to help protect offspring liver from damage.
Methods
Animals and treatments
Twenty-four ten week old female virgin SD rats were pur-
chased from the experimental animal center of Jiangsu
University. All rats were housed in pairs at 20–24 °C and
40–60 % humidity on a 12 h light–dark cycle with adlibi-
tum access to food and water.
After one week of acclimatization, the rats were ran-
domly divided into a 1:2 ratio. All rats received a normal
chow diet (20 % protein) until pregnancy was confirmed
through the presence of a post-copulatory plug and vaginal
smear the next morning. All of the males were removed
after the females became pregnant. The pregnant rats were
fed either a normal diet or a 1 % sodium butyrate diet until
the end of the lactation period. The above foods were all
customized from the Jiangsu Xie Tong Company. SB was
blended into the normal diet as it was formed, and the
food was stored at 4 °C after it was pelleted.
The slaughter and sampling procedures complied with
the “Guidelines on Ethical Treatment of Experimental
Animals” (2006) No.398 set by the Ministry of Science
and Technology, China.
Blood and tissue sample collection
At 21 days of age, the weaning rats and mothers were
weighed and anesthetized with an intraperitoneal injec-
tion of Nembutal, and then they were euthanized. Blood
was drawn from the abdominal aorta and centrifuged at
3000 rpm for 10 min at 4 °C for serum collection.
Serums were stored at −20 °C until they were analyzed.
The fresh livers from the weaning rats and the subcutane-
ous adipose tissue derived from the mothers were immedi-
ately removed and weighed after laparotomy. The samples
were snap-frozen in liquid nitrogen and stored at −80 °C.
Assay of serum concentration of cholesterol and hepatic
contents of cholesterol and fatty acids
Serum concentration of total cholesterol (Tch) was mea-
sured with a biochemical automatic analyzer (Hitachi
7020; HITACHI) using a commercial cholesterol assay kit
(E1015; Applygen Technologies, Inc.). Serum concentra-
tions of LDL-cholesterol (LDL-C) and HDL-cholesterol
Zhou et al. Lipids in Health and Disease  (2016) 15:119 Page 2 of 8
were measured with a biochemical automatic analyzer
(Hitachi 7020; HITACHI) using a commercial cholesterol
assay kit (KP712, KF253 Wako Pure Chemical Industries,
Ltd. Wako), respectively. Serum concentration of TG was
measured with a biochemical automatic analyzer (Hitachi
7020; HITACHI) using a commercial TG assay kit (E1013;
Applygen Technologies, Inc.). Serum non-esterified fatty
acid (NEFA) concentrations were determined using the
Wako NEFA Cacyllcoenzyme A synthetase acyl-coenzyme
A oxidase assay method. Hepatic total cholesterol concen-
tration was measured using a tissue total cholesterol assay
kit (E1015; Applygen Technologies, Inc.) following the
manufacturer’s instructions. Hepatic concentration of total
triglyceride was quantified with a biochemical automatic
analyzer (Hitachi 7020; HITACHI) using a commercial
TG assay kit (E1013; Applygen Technologies, Inc.).
Assay of maternal serum concentration of fatty acid
composition
Serum fatty acids (FAs) composition was analyzed accord-
ing to the method of Hossain Z [26]. Briefly, total lipids
from the serum were extracted with chloroform-methanol
(2:1, vol:vol) containing 0.01 % butylated hydroxytoluene
(Sigma-Aldrich) by using heptadecanoic acid as an internal
standard (Sigma-Aldrich). The fatty acid extracts were
methylated with methanolic hydrochloric acid. The fatty
acid methyl esters were analyzed by an Agilent 6890 N gas
chromatograph with a flame ionization detector (Agilent
Technologies) as mentioned. Serum FAs are shown as per-
centage (%, wt/wt) composition. The gas chromatograph
was equipped with a split/split less injector, and the column
was a fused silica DB-225MS capillary column (30 m×
0.25 mm thickness; Supelco). The gas chromatograph oven
was programmed as follows: 70 °C for 2 min, increase
25 °C/min, 190 °C for 3 min, increase 2 °C /min, 220 °C for
15 min, increase 45 °C, and finally 250 °C for 10 min. Sam-
ples were run with a 5:1 split ratio, and helium was used as
the carrier gas with a column flow rate of 0.8 ml/min.
Temperature for the injector was operated at 280 °C.
Temperature for the combustion reactor was set at 960 °C.
The fatty acids were determined by comparing the peak re-
tention times with standards (Sigma, St Louis, MO).
Protein extraction and Western blot analysis
Total proteins were extracted from 60 mg of frozen liver
samples as described previously. Protein concentrations
were determined using a Pierce BCA Protein Assay kit
(Pierce, Rockford, IL, USA). 48 μg of liver protein was
then loaded onto 10 % or 15 % SDS-PAGE gel. Western
blot analysis of target proteins was carried out according
to the protocols provided by the manufacturer. The pri-
mary antibodies used in the Western blot analysis are
listed in Table 1. GAPDH or β-actin was used as the
loading control in the Western blot analysis.
Statistical analyses
The results from the experiment were analyzed using the
statistics software SPSS for Windows version 20.0.
Independent-samples T-Test was used to analyze all data.
The results were presented as the mean ± standard error
(SE). Differences were considered statistically significant
when the p value was less than 0.05. Numbers of replicates
used in the experiment were noted in the tables and figures.
Results
Body weight, liver weight and litter size
The mother’s body weight showed no significant changes
between the Control (Con) group (315.16 ± 9.67) and the
SB group (376.56 ± 9.18). The litter weight in the Con
group (102.00 ± 2.92) was not significant compared to the
SB group (107.03 ± 3.20). The litter size in the Con (n = 6)
was (13.85 ± 0.34) compared to the SB group (16.00 ± 0.53).
The offspring weight and liver weight in the Con
group in the weaning rats were comparable to the SB
group (P < 0.05), as is shown in Table 4.
Maternal serum NEFA, triglyceride, lipoprotein lipase and
cholesterol concentration
As is shown in Table 2, serum content of NEFA was
significantly increased (P < 0.05) in the sodium butyrate–
Table 1 Antibodies used in our experiment
Antibody description Company Item No. Dilution ratio
ACSL1 santa cruz sc-49008 1:200
ACSS1 santa cruz sc-373847 1:200
SCD1 santa cruz sc-14720 1:200
PPARγ bioworld BS-1587 1:500
SREBP1 santa cruz sc-366 1:200
HSL bioworld BS2742 1:500
P-HSL santa cruz sc-139656 1:500
ATGL bioworld BS6757 1:500
CPT1α abcam ab83863 1:500
UCP3 bioworld BS6757 1:500
GPR43 santa cruz sc-32906 1:200
PKA bioworld BS2648 1:500
SREBP2 santa cruz sc-13068 1:200
HMGCR bioworld BS6625 1:500
CYP27A1 bioworld bs2192 1:200
LXR santa cruz sc-13068 1:200
LDLR proteintech 10785-1-AP 1:1000
C/EBPβ santa cruz sc-150× 1:200
FABP1 bioworld BS7533 1:500
CD36 bioworld BS7861 1:500
GAPDH bioworld MB001H 1:10000
β-actin bioworld AP0060 1:10000
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supplemented rats compared with the Con group, though
the maternal serum Tch, TG, LDLC and HDLC showed
no obvious changes. The serum concentrations of LPL in
the mothers also demonstrated no difference.
The fatty acid composition of the maternal serum
The fatty acid composition of the maternal serum is shown
in Table 3. The other fatty acid components tested did not
change significantly, except the Cis-9-Oleic Methyl ester
(c18:1n9c), which increased significantly compared to the
Con group.
The concentration of Tch and TG in offspring liver and
serum
As is shown in Table 4, the serum content of NEFA was
significantly increased (P < 0.05) in the sodium butyrate-
supplemented rats. No significant changes in concentra-
tions of TG were observed in the offspring serum. However,
the offspring serum content of total cholesterol, LDL-C and
HDL-C were significantly increased (P < 0.01) compared to
the Con group. Moreover, the hepatic concentration of TG
and Tch in offspring born to the sodium butyrate supple-
mented group increased significantly (P < 0.05).
Expression of proteins related to lipid metabolism in the
maternal subcutaneous adipose tissue
As is shown in Fig. 1, the proteins involved in lipolysis,
including ATGL, HSL and P-HSL were significantly
higher in the SB group (P < 0.05) (Fig. 1b). Yet, no signifi-
cant changes were detected for the content of proteins
long-chain acyl-CoA synthetase-1 (ACSL1), Acyl-CoA
Synthetase-1 (ACSS1), stearyl coenzyme A dehydrogenase
(SCD) (Fig. 1a), or in the content of SREBP1c and PPARγ
in the subcutaneous adipose tissue (Fig. 1a). Moreover, the
protein content of carnitine palmitoyltransferase (CPTI-α)
1A and UCP3uncoupling protein 3 involved in energy me-
tabolism did not change in the SB group compared with
the Con group (Fig. 1b). In addition, the content of pro-
teins GPR43 and PKA were significantly higher in the SB
group (P < 0.05) (Fig. 2).
Expression of proteins related to lipid metabolism in the
offspring liver
The results showed that the LDLR protein active in
cholesterol uptake increased significantly in the SB
group compared with the Con group (Fig. 3c). While,
the proteins expression involved in cholesterol syn-
thesis, including 3-hydroxy-methyl-glutaryl-CoA reduc-
tase (HMGCR) and Sterol Regulatory Element Binding
Protein2 (SREBP2) showed no significant changes (Fig. 3a).
Additionally, the proteins related to cholesterol deg-
radation, such as sterol 27-hydroxylase (CYP27A1), liver
X-activated receptor (LXR) (Fig. 3b) remained unchanged
compared to the Con group.
The protein content of FABP1 and CD36 related to fatty
acid transport in the offspring liver increased significantly
(Fig. 4c), though proteins related to TG synthesis such as
ACSS1, ACSL1, FAS (Fig. 4a), sterol regulatory element
binding protein 1 (SREBP1) and CCAAT-enhancer
binding proteins (CEBPβ) (Fig. 4b) were the same in
both groups. Meanwhile, no alterations were detected
in the content of P-HSL protein levels in two groups
(Fig. 4c).
Table 2 Serum concentration of total cholesterol, triglyceride
and non-esterified fatty acid in maternal rats (n = 6)
Variables Con SB P-value
Tch (mmol/L) 1.84 ± 0.18 1.60 ± 0.10 0.77
TG (mmol/L) 0.48 ± 0.07 0.52 ± 0.06 0.68
HDL-C (mmol/L) 1.06 ± 0.08 0.95 ± 0.08 0.50
LDL-C (mmol/L) 0.19 ± 0.02 0.15 ± 0.01 0.92
LPL (g/L) 12.00 ± 0.87 10.71 ± 1.13 0.59
NEFA (mmol/L) 0.68 ± 0.05 0.86 ± 0.05 0.03
Tch, total cholesterol; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol;
LPL, lipoprotein lipase, NEFA, non-esterified fatty acids
Table 3 The non-esterified fatty acid composition in maternal
serum (in % of total fatty acids)
Variables Con SB P-value
c6:0 40.7 ± 3.6 30.9 ± 6.6 0.20
c14:1 12.0 ± 0.7 14.7 ± 2.1 0.21
C18:0 9.6 ± 2.0 11.0 ± 2.5 0.69
c18:1n9c 14.3 ± 2.2 22.9 ± 3.1 0.05
c18:2n6c 11.6 ± 0.2 10.1 ± 1.3 0.31
c20:4n6 5.8 ± 1.2 3.1 ± 0.8 0.10
c6:0, caproic acid; c14:1, myristoleic acid; C18:0, stearic acid; c18:1n9, oleic
acid;c18:2n6c, linoleic acid; c20:4n6, arachidontic acid
Table 4 Serum concentration of fatty acids, total cholesterol,
triglyceride and hepatic content of total cholesterol, triglyceride
in weaning rats, body weight and liver weight
Variables Con SB P-value
Body weight (g) 68.51 ± 1.64 67.67 ± 3.06 0.81
Liver weight (g) 3.20 ± 0.13 3.18 ± 0.18 0.80
HepaticTch (mmol/L) 4.39 ± 0.07 5.42 ± 0.30 0.00
HepaticTG (mmol/L) 15.83 ± 1.17 22.72 ± 2.57 0.04
Serum Tch (mmol/L) 2.88 ± 0.09 3.43 ± 0.14 0.00
Serum TG (mmol/L) 0.76 ± 0.14 0.76 ± 0.20 1.00
Serum HDL-C (mmol/L) 1.20 ± 0.03 1.50 ± 0.07 0.00
Serum LDL-C (mmol/L) 0.99 ± 0.06 1.25 ± 0.07 0.01
Serum NEFA (mmol/L) 0.51 ± 0.05 0.65 ± 0.04 0.05
Tch, total cholesterol; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol; NEFA,
non-esterified fatty acid
(Mean values with their standard errors, n = 6)
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Discussion
It is well established that resistant starch and dietary fibers
can produce SCFA, which can raise intestinal and circulat-
ing SCFA, including butyrate acid. Besides acting as an
important energy source of the colonocytes, butyrate is of
special interest for its countless positive effects on the gut
and other tissues [27]. In a rodent obesity model, both
supplementation with butyrate and oral administration of
acetate have been demonstrated to suppress weight gain
[12]. In a maternal diet, supplementing with butyrate has
been shown to increase reproductive performance and en-
hanced anti-oxidant capacity [28]. In the present study,
we demonstrated for the first time (as far as we know) the
influence of a butyrate supplement on maternal and off-
spring lipid metabolism.
The present study demonstrated that the increasing
concentration of serum NEFA in maternal serum was
consistent with the increasing lipolysis in the adipose tis-
sue. The higher protein expressions of ATGL, HSL and P-
HSL were observed in maternal adipose tissue from the SB
group. ATGL could stimulate lipid mobilization when it
was localized at the lipid droplet surface, and it could
catalyze the original step in TG hydrolysis [29, 30]. HSL
was thought to be the rate-limiting enzyme of the first lipo-
lytic step [30, 31]. Moreover, previous studies have shown
that oleic acid has a potentially protective effect on cancers
and cell growth [32]. Similarly, an increased composition
of oleic acid was found in our present study. Meanwhile,
we investigated the protein levels involved in lipogenesis,
including ACSL1, ACSS1, SCD and the key nuclear
transcription factors containing PPARγ and SREBP1;
none of these showed obvious changes.
GPR43 is one of the FA receptors and is present in
many different kinds of tissues, including adipose tissue.
Fig. 1 Effect of maternal sodium butyrate on lipid metabolism in maternal adipose tissue. a The expression of proteins related to lipogenesis.
b The expression of proteins involved in lipolysis. Values are mean ± SEM, *P < 0.05, compared with control (n = 6)
Fig. 2 The GPR43 (a) and PKA (b) protein content in maternal adipose tissue. Values are mean ± SEM, *P < 0.05, compared with control (n = 6)
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In order to understand the relationship between sodium
butyrate and maternal lipolysis, we determined the GPR43
protein expression in the maternal adipose tissue. Notably,
the GPR43 protein level was elevated in the present study.
It has been shown that butyrate can activate PKA through
cAMP after binding the receptor [33], and other research
has demonstrated that PKA can activate and phosphoryl-
ate the downstream molecules of HSL [33–35]. In the
present study, the results showed that the PKA protein
level increased significantly in the SB group. All of
our results taken together showed that sodium butyrate
increased the protein expression of GPR43, which elevated
the P-HSL through the higher PKA protein level.
To further clarify the effect of a maternal sodium
butyrate supplement on offspring lipid metabolism, we
measured the serum lipid indexes in the offspring. Our re-
sults found that the concentration of serum NEFA in the
SB group is significantly higher than in the Con group.
When this result is considered in association with the in-
creased maternal serum NEFA, it may be inferred that the
enhanced maternal serum NEFA may have increased the
transport capacity in the placenta and resulted in the
increased serum NEFA in the offspring. Also, there is
a report exhibiting that a maternal SB supplement
can increase the fatty acid transport in the placenta [36].
However, we supplemented the SB during gestation and
the lactation period; therefore, it is also possible that the
maternal NEFA was transported through the milk [37].
Further study is needed to clarify this issue.
The liver is a main actor in the process of fatty acid
metabolism, and the present results showed a higher
hepatic content of TG and Tch after maternal butyrate
treatment. We further investigated the expression of
lipid metabolism related proteins in the offspring liver.
Previous studies have suggested that the fatty acid-binding
protein known as FABP1 is present at high levels in
murine liver [38], and it is a key regulator of hepatic lipid
metabolism and acts as an intracellular acceptor of fatty
acids following their cellular uptake and trafficking [39].
The increased FABP1 protein expression in the offspring
liver in the present study indicates a higher uptake of free
fatty acids, and these findings are consistent with the
higher concentration of NEFA in the offspring serum. The
main membrane proteins associated with FABPs are the
fatty acid transfer proteins (FAT/CD36 and FATP) [40].
We thus found a significant up-regulation of CD36 pro-
tein levels in the offspring liver of the maternal sodium
butyrate group. Another important finding of the present
Fig. 3 Effect of maternal sodium butyrate on hepatic expression of cholesterol metabolic proteins in weaning rats. a Protein expression of
SREBP2 and HMGCR; b Protein expression of CYP27A1 and LXR; c Protein expression of LDLR. Values are mean ± SEM, *P < 0.05, compared with
control (n = 6)
Fig. 4 Effect of maternal sodium butyrate on hepatic expression of lipid metabolic proteins in weaning rats. a Proteins involved in lipogenesis; b Protein
expression of SREBP1 and CEBP-b. c Protein expression of P-HSL,FABP1 and CD36. Values are mean ± SEM, *P< 0.05, compared with control (n= 6)
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study is the higher LDLR protein levels in the offspring
liver of those exposed to the maternal sodium butyrate
supplement. LDL particles are the main carrier of choles-
terol to peripheral tissues in mammals, and the hepatic
LDLR is important for maintaining cholesterol homeosta-
sis [41]. These results are in agreement with the elevated
Tch in the offspring liver treated with maternal sodium
butyrate. However, the other proteins related to lipogen-
esis and lipolysis detected in the present study showed no
obvious changes compared with the control group. It is
possible that the increased offspring hepatic lipid depos-
ition in the maternal SB group resulted mainly from the
increased hepatic lipid uptake from the circulating serum.
Conclusion
In summary, SD rats treated with maternal sodium
butyrate throughout gestation and lactation showed in-
creased lipolysis in the maternal adipose tissue and in lipid
accumulation in the offspring liver. Follow-up studies are
needed to identify the possible pathway of fatty acid trans-
port between mother and offspring after the maternal so-
dium butyrate supplement was administered.
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